GKB Ophthalmics P/B Ratio
GKB Ophthalmics (GKB) P/B ratio is 0.62 (Low), book value per share ₹110.00 — Low - Trading below book value, may indicate undervaluation. View GKB yearly price range for the annual high/low range and current price position.
Current Valuation Metrics
Book Value Breakdown (2026)
Valuation Signal
Sector Context
GKB P/B Ratio — Valuation Insights & Book Value Analysis
GKB Ophthalmics price-to-book ratio interpretation, valuation status and historical context — current P/B 0.62 (Low). Review GKB P/E ratio to evaluate earnings-based valuation against sector peers.
- Stock appears undervalued with PB of 0.62, trading below book value
- Trading below book value - potential value opportunity or financial distress signal
- Trading at premium to sector average PB of 0.0
GKB Ophthalmics P/B Ratio Historical Trend
GKB annual price-to-book ratio — 5 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. For live price, earnings yield and the full fundamental profile, see GKB share price screener.
GKB Historical P/B Ratio — Book Value Per Share & Year-End Price
GKB Ophthalmics annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2026 | 0.57 | ₹110.0 | ₹63.03 | ₹55 | Low |
| 2025 | 0.46 | ₹112.0 | ₹51.24 | ₹56 | Low |
| 2024 | 0.77 | ₹128.0 | ₹98.75 | ₹64 | Low |
| 2023 | 0.75 | ₹134.0 | ₹100.06 | ₹67 | Low |
| 2022 | 0.83 | ₹134.0 | ₹110.70 | ₹67 | Low |
GKB vs Healthcare Peers — P/B Ratio Comparison
GKB Ophthalmics P/B 0.62 vs Healthcare average 0.0, median 0.6 — range -6.55–1.14.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Parmax Pharma | PARMAX | -6.55 | ₹46 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -2.14 | ₹70 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.74 | ₹118 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |
| Vivimed Labs | VIVIMEDLAB | -0.16 | ₹43 | Low |
| Triochem Products | TRIPR | 0.04 | ₹0 | Low |